EPCR promotes MGC803 human gastric cancer cell tumor angiogenesis in�vitro through activating ERK1/2 and AKT in a PAR1‑dependent manner-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EPCR promotes MGC803 human gastric cancer cell tumor angiogenesis in�vitro through activating ERK1/2 and AKT in a PAR1‑dependent manner

Published:2018-06-01 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Wang Qingling¹,Tang Yangyang¹,Wang Tianyuan¹,Yang Hong‑Li¹,Wang Xinyue²,Ma Hongru³,Zhang Peng⁴

Affiliation:

1. Department of Pathology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China

2. School of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China

3. School of Clinical Medicine, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China

4. Jiangsu Key Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of endothelial protein C receptor as a novel druggable agonistic target for reendothelialization promotion and thrombosis prevention of eluting stent;Bioactive Materials;2024-11

2. Bioinformatics Analysis Reveals the Vital Role of AKR1B1 in Immune Infiltration and Clinical Outcomes of Gastric Cancer;DNA and Cell Biology;2023-07-01

3. Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer;Scientific Reports;2023-06-12

4. Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer;International Journal of Molecular Sciences;2022-03-17

5. Myricetin reverses epithelial–endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1;Phytotherapy Research;2022-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3